The glycosidase inhibitors, cyclophellitol, nagstatin and gualamycin, which are microbial metabolites, and their analogs have been synthesized from carbohydrates to clarify their structure -activity relationships. The synthesis of cyclophellitols including the aziridine and thiirane analogs was mainly based on the stereospecific intramolecular [3+2]cycloaddition of a nitrile oxide to an olefm. Nagstatins including a variety of hydroxyl analogs were synthesized by inter-and intramolecular nucleophdic reaction of the imidazole moieties. Their glycosidase inhibiting activities were quite substrate-specific, indicating that the glycosidases recognize especially each carbons and configurations of the glycosidase inhibitors, and consequently, the inhibitors serve as antagonists of the corresponding glycopyranosides. Total synthesis of gualamycin was accomplished by glycosylation of a thio-phenol derivative of the disaccharide portion with a pyrrolidine-aglycone. The anti-mite activity of gualamycin was suggested to be due to its maltase inhibiting activity.
Introduction
In recent years, much attention has focused on the synthesis and development of glycosidase inhibitors because of an increasing awareness of the vital role played by carbohydrates in biological processes. The glycosidase inhibitors fmd utility as antiobesity drugs, antidiabetes, antifungals, insecticides, and antivirals, including substances active against the human immunodeficiency virus (W) and metastasis. Therefore, the chemical and biochemical studies on glycosidase inhibitors may enable us to understand the processes of intractable diseases such as diabetes mellitus, cancer and AIDS, and may also provide us therapeutic approaches to them. As part of an ongoing program to clarify the mode of action of glycosidase inhibitors, we have synthesized cyclophellitol, nagstatin and gualamycin, and their analogs having different configurations and functionalities.
Cyclophellitd
Cyclophellitol (1) is a novel P-D-glucosidase inhibitor isolated from culture filtrates of a mushroom, Phellinus sp., and structurally, is a fully oxygenated cyclohexane corresponding to a carba analogue of Dglucopyranose (ref. 1). Cyclophellitol(1) and its analogs (2 -7) have been enantiospecifically synthesized from carbohydrates to clarify their mode of action in glycosidase inhibition in our laboratories (ref. 2 -6) .
Recently, the elegant synthesis of 1 was reported by several groups (ref. 7). Our strategy for construction of these highly oxygenated compounds is an intramolecular cycloaddition of a nitrile oxide to an alkene (ref. Swern oxidation of 8, which was derived from L-glucose, afforded the unstable aldehyde, which was subjected to Wittig alkenation with salt-free methylidene-triphenylphosphorane to afford the alkene 9. This was hydrolyzed with aqueous HCl in dioxane to an idopyranose derivative, which was treated with hydroxylamine hydrochloride in pyridine to give the oxime 10. Intramolecular cycloaddition of 10 was realized by using NaOCl via the intermediary nitrile oxide to afford the isoxazoline 11 as a single product in 70% yield. The stereochemistry was confirmed by 1H-NMR studies of compounds 11 -14 and, finally the completion of the synthesis presented next. The isoxazoline opening was achieved by treatment of 11 with H2 and Raney Ni-W4 in aq. dioxane in the presence of AcOH to afford the keto-diol 12. After silylation with diethylisopropylsilyl triflate, the resulting ketone was reduced with BH3-Me2S to afford the desired a-alcohol 13. Diethylisopropylsilyl (DEIPS) group was developed in our laboratories and effectively used as an 0-protecting group, because this silyl group was found to be readily removed under hydrogenolysis conditions using Pd(OH)2 (ref. 8). Mesylation of 13 provided the labile mesylate, which was subjected to hydrogenolysis with Pd(OH)2 in MeOH to give the deprotected 14, followed by epoxidation with MeONa to give cyclophellitol(1).
In order to provide additional insight into the mode of action of cyclophellitol (l), the unnatural epoxide diastereomers (2 -3) and heteroatom-containing analogs (4 -7) were synthesized. From the fact that cyclophellitol (1) exhibits a very high P-D-glucosidase inhibiting activity, we have expected that 1,6-epicyclophellitol (2) and a-manno analog 3 inhibit a-D-glucosidase and a-D-mannosidase activities, respectively.
1,6-Epicyclophellitol(2) was similarly synthesized from methyl 2,3,4-tri-O-benzyl-a-D-galactopyranoside through the isoxazoline 15, which was subjected to acidic hydrogenolysis with Raney Ni-W4 to afford the desired keto-alcohol16 with epimerization at the C-1 position. The a-manno analog 3 was synthesized from 15 without epimerization at C-1 position. The hydrogenolysis of 15 was conducted using Raney Ni and B(OH)3 to afford the keto-alcohol17 in a quantitative yield, which was converted into 3 (ref. 4 The aziridine analog 4 was synthesized from 1,6-epicyclophellitol(2). The tetra-O-benzyl derivative of 2 was treated with NaN3 to afford a mixture of 18 and 19, which was subjected to reduction with PPh3 to give a single aziridine, followed by de-O-benzylation to give the P-aziridine analog 4 (ref.
4).
Similarly, the a-aziridine 5 was derived from cyclophellitol (1) . The thiirane analogs 6 and 7 were prepared from 2 and 1, respectively, by treatment of their O-MPM derivatives with Ph3P=S and trifluoroacetic acid, followed by de-O-methoxybenzylation with DDQ (ref.
5).
The glycosidase inhibiting activities of cyclophellitol (1 Table 1 .
In dramatic contrast to natural cyclophellitol(1) which inhibited only P-D-glucosidase activity for 50% at 0.8 mg/ml, the epi-epoxide 2 exhibited the inhibiting activity only against a-D-glucosidase at IC50 10 mg/ml. The a-manno analog 3 expectedly showed inhibitory activity against a-mannosidase of IC50 19 mg/ml, and the P-aziridine analog 4 showed very high inhibitory activity against P-glucosidase of IC50 0.22 mg/ml, while the a-aziridine 5 showed little a-glucosidase inhibiting activities. Remarkably, both thiirane analogs 6 and 7 showed no significant activities. Structurally, cyclophellitol (1) and its aziridine analog 4 have quasi-equatorially oriented C1-0 and CI-N bonds, which correspond to the equatorial C 1-0 bond of P-D-glucopyranosides, whereas epi-cyclophellitol Similarly, the enantiomeric N-acetyl-L-galactosamine analog 21 ' and L-galactose analog 22' were prepared from D-ribofuranose derivative by the same procedures as mentioned above. Furthermore, nitrogenous N-acetyl-D-glucosamine, D-glucose and D-mannose analogs (23.24 and 25) were efficiently prepared from L-xylofuranose derivative by the similar fashion as described above. Now, the next step is set for the enantiospecific synthesis of nagstatin (1). The rational starting point is the aforesaid isomers 28 and 30 (ref. 12). The regioselective introduction of an allyl group on their C-2 positions was investigated under a variety of conditions. The C-2 position is generally known to be less reactive than the C-3. In fact, selective bromination of 31 gave the undesired C-3 bromo compound 32. Accordingly, 31 was fully brominated with 2,4,4,6-tetrabromo-2,5-cyclohexadien-1 -one to the dibromo compound 33, the selective debromination of which was assayed. The best result was realized by regioselective lithiation with t-BuLi in THF followed by quenching with H 2 0 to give the desired monobromo compound 34. The structure was confirmed by the lH-NMR NOE studies of the corresponding allyl derivative 35. Dihydroxylation with OsO4 and NMO of 35 afforded 36, which was oxidized by using modified Fetizon's conditions using Ag2C03 to give the keto-alcohol37. Periodate oxidation followed by esterification with TMSCHN2 provided the methyl ester 38. Direct ozonolysis of 35, or periodate oxidation of 36 caused concomitant oxidation at C-9 position. Conversion of 38 to the azido compound 39 was carried out by de-O-silylation followed by treatment with HN3, n-Bu3P and DEAD. Expected retention of the configuration was observed at the C-8 position as described above. Hydrogenolysis of 39 followed by successive N-acetylation and saponification with aq. NaOH provided nagstatin (20) , which was identical with the natural product in all respects including glycosidase inhibiting activities. The completion of the synthesis confirmed the absolute structure 20. In a similar manner, but with inversion of the configuration, the other C-8 axial isomer 28 was converted into the aforesaid azido compound 39 in a ten-step sequence through the ally1 derivative 40.
The glycosidase inhibiting activities were assayed as described above (ref. 11) and summarized in Table 1 . 14 -15). The structural complexity, as well as the goal of studying structure-activity relationships, prompted us to an exploration of the total synthesis, which was expected to confirm the absolute structure 41 and elucidate the origin of appearance of the acaricidal activity. The synthesis is mainly based on glycosylation of the glycosyl acceptor 57 with the donor 60 (ref. 16 ). The pyrrolidine-containing aglycone unit 43 was synthesized from the azido sugar 44, which was prepared by de-O-acetylation of t-butyldimethylsilyl3,4,6-tri-O-acetyl-2-azido-2-deoxy-a-L-mannopyranoside. The azide 44 was selectively silylated with TBDMSCl and methoxymethylated to the fully protected product, which was selectively desilylated to give the alcohol. Swern oxidation gave the labile aldehyde 45, which was treated with the Wittig reagent prepared from (4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyltriphenylphosphonium iodide (46) and n-BuLi, successively followed by removal of the isopropylidene group and tritylation of the resulting primary alcohol to yield the cis olefin 47. The cis dihydroxylation of 47 by OsO4 gave two triols 48 and 49 in 34% and 46% yields, respectively. Their configurations were determined by the *H-NMR studies of their corresponding isopropylidene derivatives 50 and 51 to show that 49 was the desired triol for the natural product. The triol 49 was methoxymethylated, followed by successive treatment with Ph3P in PhMe and with aq. THF in refluxing to give the amino compound, which was tosylated to the product 52. Desilylation with n-Bu4NF and hydride reduction with NaBH4 gave the alcohol 53. This was selectively methoxymethylated and then submitted to the S~2 -t y p e cyclization using Ph3P and DEAD to give the pyrrolidine derivative 54. After detritylation by hydrogenolysis, the forming alcohol was oxidized stepwise by Swem's conditions to give the aldehyde and by sodium chlorite oxidation with HzNSO3H to give the carboxylic acid 55. De-N-tosylation by Birch's conditions with Li in liq. NH3 followed by esterification with 5% HCl-MeOH gave the hydrochloride of the pyrrolidine-aglycone 43, which was identical with the naturally derived sample in all respects. 
N-Acetyl-D-galactosamine

41: Gualamycin
53
54
PTBS
The glycosyl acceptor, di-0-benzylidene derivative 57 was synthesized by a 5-step sequence from the aglycone 43. Thus, treatment of 43 with Na2C03 to give the &lactam whose 0-benzylidenation with PhCHO and ZnC12 provided 56 in 54% overall yield. The two sets of two hydroxyl groups at the C-3 and 4 positions and at the C-6 and 9 positions were effectively protected by 0-benzylidene groups as expected from the Dreiding model. The protection of the hydroxyl group at C-7 in 56 proceeded nonselectively under a variety of conditions, while the glycosylation of 56 gave unexpectedly the undesired ,7-0-glycosyl derivative by using the glycosyl donor 60. Accordingly, 56 was silylated with TMSCl and DIPEA, acetylated and desilylated to give the monoacetate 57 in 70% yield. The glycosyl donor 60 was prepared from phenyl-1-thio-galactoside in five steps through 58. The alcohol 58 was subjected to the reaction with the protected gulosaminyl bromide 59 in the presence of AgOTf and scollidine to give the glycosyl donor 60.
Coupling of 60 with the acceptor 57 was accomplished by using a modified Fraser-Reid's conditions using NIS and TfOH at -40°C for 1 hour to provide exclusively the desired a-glycoside 61. Only the low yield of 41 was observed. However, the convenience of using acids to catalyze the process was especially appealing to us. Hydrolysis of the lactam was successfully conducted in 2M HC1 at room temperature for 6 days to give the dihydrochloride of gualamycin (41) in 86% yield without further hydrolysis, which was identical w i t h the natural product in all respects including acaricidal activities.
When the glycosidase inhibiting activities were assayed, gualamycin (41) was found to inhibit maltase activity at IC50 25 mg/ml. This inhibiting activity seems to be the origin of appearance of the acaricidal (antimite) activity, suggesting that a mite could get maltose as a source of life.
Conclusions
The glycosidase inhibitors, cyclophellitol, nagstatin and gualamycin, which are microbial metabolites, and their analogs were effectively synthesized from carbohydrates to clarify their structure -activity relationships. As a result, new analogs having stronger activities than natural products were chemically designed and created. Their glycosidase inhibiting activities were quite substrate-specific, indicating that the a-and P-glycosidases recognize especially the C-1 positions and the residual portions as corresponding to those of a-and P-glycopyranosides, and consequently, the inhibitors serve as antagonists of the corresponding glycopyranosides. The anti-mite activity of gualamycin was suggested to be due to its maltase inhibiting activity.
